Cimzia® - an exciting new option in RA therapy
-In clinical trials, CIMZIA has been shown to reduce RA pain, stiffness, and fatigue as fast as 1 to 2 weeks. Many patients on CIMZIA experienced lasting relief at both 6 months and 1 year.
-A new syringe designed in partnership with OXO GOOD GRIPS®
-The online, phone, and financial support of CIMplicity™
CIMZIA (certolizumab pegol) is a medicine used to treat adults with moderately to severely active rheumatoid arthritis.
CIMZIA is referred to as an "anti-TNF therapy". By blocking tumor necrosis factor (TNF)-alpha, CIMZIA helps reduce the inflammation, stiffness and joint damage RA causes.
CIMZIA is taken by an injection under the skin. After initial doses, CIMZIA can be injected every 2 or 4 weeks. CIMZIA may be taken with or without other RA medications like methotrexate.
Rheumatology Specialty Center performs the infusion service in all of our Offices. We also infuse other medications in our facilities depending on the medication ordered by our Physicians, and the needs of our patients.
|
|